See more : Critical Solutions, Inc. (CSLI) Income Statement Analysis – Financial Results
Complete financial analysis of Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Chunghwa Chemical Synthesis & Biotech Co., Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
- The Foschini Group Limited (FHNGY) Income Statement Analysis – Financial Results
- Zalemark Holding Company Inc. (ZMRK) Income Statement Analysis – Financial Results
- Australian Agricultural Company Limited (AAYYY) Income Statement Analysis – Financial Results
- ACME Lithium Inc. (ACLHF) Income Statement Analysis – Financial Results
- Vitec Software Group AB (publ) (0RDI.L) Income Statement Analysis – Financial Results
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW)
About Chunghwa Chemical Synthesis & Biotech Co., Ltd.
Chunghwa Chemical Synthesis & Biotech Co., Ltd. engages in the research, development, manufacture, and wholesale of active pharmaceutical ingredients (APIs) in Taiwan and the United States. It offers API products, which include immunosuppressant, oncology, cardiovascular, and other products, as well as peptide drugs. The company also develops bulk pharmaceutical products, such as anti-anxiety agents, antidiabetics, laxatives, antifungals, antihistamines, antiseptics, antiulcerants, cardiovascular drugs, skeletal, muscle relaxants, hypolipaemics, antineoplastic, antihyperlipedemias, and immunosuppressant products, as well as provides research and development, and contract manufacturing services to new drug developers and generic drug companies. The company was formerly known as China Chemical Synthesis Industry Co., Ltd. Chunghwa Chemical Synthesis & Biotech Co., Ltd. was founded in 1964 and is headquartered in New Taipei City, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.09B | 2.12B | 1.93B | 1.54B | 1.16B | 1.02B | 1.17B | 1.20B | 1.16B | 946.70M | 1.04B | 1.33B | 1.20B | 1.20B | 1.13B |
| Cost of Revenue | 1.33B | 1.16B | 985.31M | 856.84M | 688.01M | 667.94M | 760.38M | 784.21M | 755.74M | 649.95M | 668.49M | 809.29M | 747.08M | 745.35M | 598.40M |
| Gross Profit | 757.31M | 961.76M | 949.39M | 686.75M | 468.63M | 351.51M | 407.87M | 414.46M | 406.47M | 296.76M | 374.99M | 520.30M | 453.50M | 451.89M | 528.45M |
| Gross Profit Ratio | 36.30% | 45.43% | 49.07% | 44.49% | 40.52% | 34.48% | 34.91% | 34.58% | 34.97% | 31.35% | 35.94% | 39.13% | 37.77% | 37.74% | 46.90% |
| Research & Development | 242.70M | 244.79M | 252.67M | 215.73M | 195.46M | 161.54M | 149.32M | 146.40M | 131.87M | 130.02M | 126.48M | 136.32M | 130.49M | 100.80M | 105.67M |
| General & Administrative | 104.63M | 109.31M | 95.23M | 92.41M | 76.45M | 80.33M | 95.79M | 83.79M | 77.63M | 63.26M | 61.88M | 71.50M | 67.91M | 56.62M | 39.61M |
| Selling & Marketing | 129.18M | 162.47M | 144.67M | 109.70M | 75.61M | 78.76M | 84.62M | 86.14M | 97.46M | 80.12M | 87.91M | 86.57M | 86.55M | 88.81M | 85.22M |
| SG&A | 233.80M | 271.78M | 239.89M | 202.10M | 152.06M | 159.08M | 180.41M | 169.93M | 175.09M | 143.38M | 149.78M | 158.07M | 154.46M | 145.44M | 124.82M |
| Other Expenses | 280.81M | 73.88M | 12.18M | 347.81M | 5.03M | 218.74M | 39.75M | 1.52M | 244.96M | 28.58M | 27.27M | 11.49M | 17.92M | 11.86M | 9.22M |
| Operating Expenses | 757.31M | 516.57M | 492.57M | 417.83M | 347.52M | 320.62M | 329.73M | 316.33M | 306.96M | 273.41M | 276.26M | 294.39M | 284.94M | 246.24M | 230.50M |
| Cost & Expenses | 1.81B | 1.67B | 1.48B | 1.27B | 1.04B | 988.56M | 1.09B | 1.10B | 1.06B | 923.35M | 944.75M | 1.10B | 1.03B | 991.59M | 828.89M |
| Interest Income | 7.27M | 4.51M | 181.00K | 424.00K | 808.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.00K | 217.00K | 56.00K | 50.00K |
| Interest Expense | 19.44M | 9.71M | 3.32M | 4.76M | 10.62M | 10.87M | 8.35M | 6.56M | 8.37M | 14.02M | 12.32M | 9.79M | 2.27M | 10.09M | 19.17M |
| Depreciation & Amortization | 193.01M | 169.05M | 131.99M | 131.15M | 129.64M | 134.76M | 134.13M | 114.71M | 102.83M | 96.49M | 83.27M | 69.71M | 65.16M | 61.80M | 87.47M |
| EBITDA | 545.93M | 743.72M | 651.27M | 786.21M | 250.75M | 165.73M | 252.01M | 214.36M | 447.31M | 148.42M | 182.00M | 289.80M | 261.56M | 348.31M | 354.63M |
| EBITDA Ratio | 26.17% | 35.13% | 33.66% | 50.93% | 24.55% | 37.84% | 21.57% | 17.88% | 38.49% | 15.68% | 20.05% | 21.51% | 22.14% | 22.12% | 34.70% |
| Operating Income | 280.81M | 574.67M | 519.28M | 655.05M | 154.36M | 30.89M | 78.14M | 98.13M | 99.52M | 23.35M | 98.73M | 225.91M | 168.55M | 205.65M | 297.96M |
| Operating Income Ratio | 13.46% | 27.14% | 26.84% | 42.44% | 13.35% | 3.03% | 6.69% | 8.19% | 8.56% | 2.47% | 9.46% | 16.99% | 14.04% | 17.18% | 26.44% |
| Total Other Income/Expenses | 52.68M | 119.77M | 59.14M | 381.38M | 22.64M | 209.35M | 31.40M | -5.04M | 236.59M | 14.56M | 14.95M | -1.40M | 25.57M | 70.76M | -49.96M |
| Income Before Tax | 333.49M | 583.31M | 497.61M | 650.30M | 143.74M | 240.25M | 109.54M | 93.09M | 336.11M | 37.91M | 113.68M | 206.46M | 194.12M | 276.42M | 247.99M |
| Income Before Tax Ratio | 15.98% | 27.55% | 25.72% | 42.13% | 12.43% | 23.57% | 9.38% | 7.77% | 28.92% | 4.00% | 10.89% | 15.53% | 16.17% | 23.09% | 22.01% |
| Income Tax Expense | 68.58M | 117.17M | 96.56M | 118.23M | 26.62M | 5.96M | 23.65M | 32.91M | 27.80M | 23.00M | 16.76M | 30.89M | 28.60M | 27.37M | 1.61M |
| Net Income | 264.91M | 465.87M | 400.78M | 531.87M | 117.00M | 234.25M | 85.77M | 60.28M | 308.36M | 14.59M | 96.83M | 175.56M | 170.99M | 187.00M | 245.11M |
| Net Income Ratio | 12.70% | 22.00% | 20.72% | 34.46% | 10.12% | 22.98% | 7.34% | 5.03% | 26.53% | 1.54% | 9.28% | 13.20% | 14.24% | 15.62% | 21.75% |
| EPS | 3.42 | 6.01 | 5.17 | 6.86 | 1.51 | 3.02 | 1.11 | 0.78 | 3.98 | 0.19 | 1.25 | 2.32 | 2.20 | 2.62 | 3.62 |
| EPS Diluted | 3.39 | 5.93 | 5.12 | 6.79 | 1.50 | 2.99 | 1.10 | 0.77 | 3.96 | 0.19 | 1.24 | 2.31 | 2.20 | 2.61 | 3.56 |
| Weighted Avg Shares Out | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 77.56M | 71.43M | 67.70M |
| Weighted Avg Shares Out (Dil) | 78.09M | 78.50M | 78.32M | 78.33M | 78.20M | 78.33M | 78.20M | 78.00M | 77.93M | 77.78M | 77.86M | 77.94M | 77.90M | 71.65M | 68.89M |
Source: https://incomestatements.info
Category: Stock Reports